Related Experiment Video
Updated: Mar 27, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
A reassessment of the PROPATRIA study and its implications for probiotic therapy
Ger P A Bongaerts1, René S V M Severijnen2
1Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.
Insights
The PROPATRIA trial found a higher mortality rate in severe acute pancreatitis patients receiving probiotics. This suggests a potential interaction between probiotics, pancreatic enzymes, and lactic acid, necessitating careful consideration in future research.
Area of Science:
- Gastroenterology
- Clinical Nutrition
- Microbiology
Background:
- Severe acute pancreatitis carries significant risks of infectious complications.
- Enteral probiotics have been explored to mitigate these complications.
- Previous studies suggested potential benefits of probiotics in related conditions.
Purpose of the Study:
- To evaluate the efficacy of a multispecies probiotic preparation in reducing infectious complications in severe acute pancreatitis.
- To investigate the safety and impact of probiotic therapy in this patient population.
Main Methods:
- A multicenter, double-blind, placebo-controlled clinical trial (PROPATRIA).
- Patients with predicted severe acute pancreatitis received either a probiotic preparation or placebo enterally.
- Mortality rates and infectious complications were monitored.
Main Results:
- The probiotic group experienced a significantly higher mortality rate (16%) compared to the placebo group (6%).
- This contrasts with previous findings and suggests a potential adverse interaction.
- Elevated lactic acid levels, possibly from bacterial fermentation, were implicated.
Conclusions:
- Probiotic therapy in severe acute pancreatitis, as conducted in PROPATRIA, may be associated with increased mortality.
- A lethal combination of pancreatic enzymes and probiotics, exacerbated by lactic acid, is hypothesized.
- Future research should carefully consider timing, carbohydrate intake, bacterial overgrowth, and probiotic dosage.
Abstract:
The PROPATRIA (Probiotics in Pancreatitis Trial) study was a multicenter, double-blind, placebo-controlled clinical trial that aimed to reduce infectious complications in patients with predicted severe acute pancreatitis by the enteral use of a multispecies probiotic preparation. An unprecedented 24 of 152 patients (16%) in the group receiving probiotics died versus 9 of 144 (6%) in the placebo group. This high mortality rate in the probiotic-treated group contrasts strongly with observations from a previous smaller study and from our observations regarding the effects of abundant intestinal lactobacilli in patients with short small bowel (SSB) syndrome. We argue here that a lethal combination of mainly proteolytic pancreas enzymes and probiotic therapy resulted in the high mortality rate of the PROPATRIA trial and that elevated levels of lactic acid produced by bacterial fermentation of carbohydrates were a key contributing factor. We suggest that probiotic therapy may not be counter-indicated for the prevention of secondary infections associated with acute pancreatitis, provided that future clinical studies (i) start probiotic therapy immediately after first onset of disease symptoms, (ii) limit the supply of fermentable carbohydrates, (iii) prevent bacterial (over)growth of patient's own intestinal flora and (iv) massively increase the dose of probiotic bacteria.
Related Concept Videos
Probiotics
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Microorganisms in Medicine and Therapeutics
Introduction to the Human Microbiota
Clinical Significance of Antibiotic Resistance

